While MDMA and psilocybin make waves throughout the medical community, another psychedelic known as ibogaine has shown promise in treating a myriad of disorders, a list which now includes post-traumatic stress disorder.
January 11, 2024
The State of Kentucky is considering spending $42 million on researching ibogaine, a powerful psychedelic that has shown promise in treating or even interrupting opiate use disorder.
November 21, 2023
A newly published analysis showcases the potential offered by psychedelics as a mental health treatment for military veterans.
October 9, 2023
The owner of a church that allegedly sold psilocybin products to its members is arguing that a police raid on their property was illegal based on a city proposal that decriminalized entheogenic plants and fungi in the city of Detroit.
September 27, 2023